CS Paper Radar

Explainable Artificial Intelligence (XAI) in Computational Pathology: Definitions, Taxonomy, and Recommendations

Shubham Innani, Suhang You, Adam Shephard, Bhakti Baheti, Francesco Ciompi, Joe Yeong, Nasir Rajpoot, Michael Feldman, Solene Florence Kammerer-Jacquet, Dimitrios Makris, Geert Litjens, Anne L. Martel, Jana Lipkova, April Khademi, Spyridon Bakas, for the MICCAI SIG-CompPath

cs.AI cs.CV ·submitted 2026-08-28 19:46 UTC · v1
published

Abstract

Computational pathology (CompPath) is transforming medicine by leveraging artificial intelligence (AI) algorithms to support diagnosis, prognosis, and treatment prediction from gigapixel whole-slide images. Clinical adoption is progressing, but is constrained by concerns about safety, accountability, and regulatory oversight in high-stakes clinical environments. Explainable AI (XAI) systems hold promise for building trust and enabling verification, yet the literature remains fragmented due to inconsistent terminology, overlapping methodological families, ad hoc validation, and current reviews. This review aims to formalize XAI methods in CompPath through the: i) introduction of a pathology-centric vocabulary comprising seven core terms; ii) development of a taxonomy across methodological families and three orthogonal axes (stage, type, scope); and iii) establishment of a task-driven framework that maps five clinical questions to recommended methods, method evaluation, and deployment context. Five key gaps between current XAI capabilities and clinical deployment are identified, and actionable steps are proposed to advance XAI for CompPath.

Comment
On behalf of MICCAI SIG-CompPath. More information: https://miccai.org/index.php/special-interest-groups/sig-comppath/

Closest papers

Nearest neighbours by meaning across the whole index.

LUCAID: Agentic Multimodal AI for Lung Cancer Precision Pathology

cs.CV cs.AIcs.LG ·2026-08-24 ·Marie-Lisa Eich, Kai Standvoss, Timo Milbich, Alexander Möllers, Miriam Hägele +28 more
similarity 0.66
Abstract

Lung cancer tissue diagnostics is complex, as therapy decisions in precision oncology rely on the integration of histomorphological, immunohistochemical, and molecular features. Yet pathological assessment remains largely visual and semi-quantitative and shows interobserver variability, while existing artificial intelligence (AI) tools cover only selected tasks, rarely reach generalizable expert-level performance, and lack prospective clinical validation. To address these challenges, we developed and clinically validated LUCAID, an agentic AI system for precision lung cancer pathology. An integrative agent couples diagnostic reasoning with nine modules that cover the full routine workflow, from quality control, tumor detection and segmentation, histological subtyping, tumor microenvironment profiling, tumor cellularity quantification, and predictive biomarker scoring (PD-L1, MET, TROP-2) to automated structured report generation. LUCAID enables users to interactively query the module outputs and generate reports that contextualize the results. Against large-scale expert ground-truth annotations, the analysis modules achieved F1 scores of 0.82-0.95. In prospective clinical validation, LUCAID reached 93.0% concordance with an expert-panel adjudicated reference standard across clinically actionable decisions, compared with 68.3-81.1% for five experienced thoracic pathologists.

0.26

TIAgent: From Natural Language to Grounded Agentic Workflows for Computational Pathology

cs.AI q-bio.QMcs.CLcs.MA ·2026-09-30 ·Aakash Madhav Rao, Mark Eastwood, Danielle Belgrave, Fayyaz Minhas
benchmark similarity 0.65
Abstract

Computational pathology (CPath) analyses increasingly depend on multi-step computational workflows that require substantial programming expertise, limiting their accessibility to pathologists and other domain experts without extensive coding experience. Although large language models (LLMs) provide a promising natural-language interface for constructing such analyses, hallucinated operations and incorrect workflow specifications limit their reliability in scientific settings. We introduce Tissue Image Analysis Agent (TIAgent), an automated CPath workflow generation framework that, given a natural-language prompt specifying a complex analytical task together with an input dataset, automatically constructs a verifiable computational graph employing existing CPath operations. The resulting graph can be inspected and executed, enabling natural-language construction of complex CPath workflows for applications including automated biomarker discovery and tissue analysis. We demonstrate end-to-end workflow generation and execution and systematically benchmark 14 backbone LLMs across 90 unit tasks spanning 18 CPath operation types. The ability of each LLM to generate a complete and correct unit workflow is quantified using Unit Workflow Success (UWS). Performance varied substantially across backbone models, with Kimi-K2.7-Code achieving the highest UWS of 0.967 (95% CI: 0.907-0.989). Analysis of node and parameter correctness further revealed that selecting the appropriate computational operation and correctly configuring it represent distinct challenges for LLM-based workflow generation. TIAgent provides a foundation for making complex CPath workflow construction more accessible while enabling systematic evaluation of LLM-driven scientific workflow generation.

0.20

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.65
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12

STEP: A Modular Silent Trial Engine for Operational Evaluation of Digital Pathology AI in Routine Workflow

cs.SE cs.CV ·2026-08-27 ·Gabriele Campanella, Matthew Croken, Olga Lukatskaya, Jane Houldsworth, Ricky Kwan +2 more
similarity 0.64
Abstract

Prospective silent trials provide an important bridge between retrospective validation of artificial intelligence (AI) models and their use in clinical care by evaluating model performance and operational reliability on live clinical data without influencing patient management. In computational pathology, conducting silent trials requires integration across laboratory information systems, digital pathology infrastructure, computational resources, and model inference pipelines, and these workflows are often implemented using application-specific software. We developed the Silent Trial Engine for Pathology (STEP), a reusable software platform for orchestrating prospective silent trials of computational pathology AI models across heterogeneous clinical and computational environments. STEP separates common trial orchestration from institution-specific data access and compute infrastructure through modular adapter interfaces. The platform supports scheduled case discovery, per-slide inference submission, deterministic idempotency, failure recovery, result and ancillary-data ingestion, persistent trial and run state, and audit logging, with compute adapters supporting local execution and high-performance computing environments using LSF and Slurm. STEP was deployed at three institutions to support prospective silent evaluation of EAGLE, an AI model for predicting EGFR mutation status from hematoxylin and eosin-stained whole-slide images. By separating trial-level workflow logic from site-specific integrations, STEP enables a common execution framework to operate across heterogeneous pathology environments while maintaining durable and auditable trial state. This approach may reduce duplicated engineering effort and facilitate systematic real-world evaluation of computational pathology AI before interventional clinical deployment.

0.24

An Agentic AI Workflow for Liver Lesion Segmentation and Structured Radiology Reporting

cs.CV cs.LG ·2026-10-25 ·Fatma Ahmed Mansour, Rahatara Ferdousi, Zyad Medhat Mahmoud Ashor, Manar Fathy Elshenawy, Ibrahim Shehaby +2 more
similarity 0.64
Abstract

Despite advances in automated liver lesion segmentation, a gap remains between image-derived predictions and clinically interpretable radiology reports. Bridging this gap requires quantitative measurements that are both reproducible and traceable. We present an evidence-grounded agentic AI framework that connects liver and lesion segmentation with deterministic quantification and structured reporting. TotalSegmentator-based nnU-Net models delineate the liver, Couinaud segments, and lesions, while computational tools extract volumes, dimensions, counts, and anatomical locations. A large language model (LLM) organizes these measurements into a predefined reporting schema, with numerical consistency checks against source measurements. On 51 LiTS cases, the segmentation stage achieved a liver Dice score of 0.947, lesion sensitivity of 75.6%, and positive predictive value of 68.9%. Exploratory screening of 25,494 MERLIN reports identified 10,208 (40.0%) with liver-related abnormalities. By connecting quantitative imaging evidence with agentic report generation, this work takes a step toward human-centered medical AI that prioritizes traceability and clinical relevance.

0.23

RAG-Enhanced LLMs for Interactive Explainability in Clinical Decision Support Systems

cs.AI cs.HCcs.LG ·2026-11-06 ·Lorenzo Mannocci, Francesca Naretto, Lucia Passaro, Anna Monreale
published similarity 0.64
Abstract · Published in HC_AIxIA_HYDRA 2025, Communications in Computer and Information Science, vol. 2830, pp. 50-63, Springer, 2026. Please cite the …

Artificial Intelligence (AI) is increasingly embedded in high-risks decision-making systems across domains such as healthcare, finance, and the judicial system. As reliance on predictive models grows, so does the demand for Explainable AI (XAI) to ensure transparency, trust, and interpretability. However, existing XAI approaches often fail to present explanations in a format accessible to domain experts, limiting their practical utility. Large Language Models (LLMs) have recently emerged as a bridge between complex models and end-users, offering natural language explanations. Yet, their use introduces new risks, including hallucinated outputs and lack of source traceability. To address these challenges, we propose a Clinical Decision Support System (CDSS) that not only combines standard predictive models with XAI techniques but also incorporates a Retrieval-Augmented Generation module as an interactive enhancer. This module grounds explanations in verified medical knowledge, reformulates technical outputs into a human-like format, and enables users-such as clinicians-to actively query the system. By fostering an interactive, human-in-the-loop environment, our approach empowers domain experts to explore model decisions, contextualize explanations, and build trust in AI-assisted diagnostics. The study concludes with preliminary experiments validating the proposed methodology.

0.20

MedPAO-VL: Interpretable and Protocol-Compliant Agent for Structured Radiology Report Generation

cs.CV ·2026-10-15 ·Shrish Shrinath Vaidya, Gowthamaan Palani, Minmini Selvam, Gokulraja Srinivasaraja, Ganapathy Krishnamurthi
published similarity 0.63
Abstract · The paper has been accepted at ECCV BISCUIT Workshop, 2026

Despite the remarkable generalization capabilities of Large Language Models, generating clinically accurate and structured radiology reports from medical images remains a significant challenge. Current end-to-end approaches function as black boxes, prone to factual hallucinations and generating ungrounded findings. This lack of reliability and failure to adhere to domain-specific structuring protocols, fundamentally limits their clinical utility. We present MedPAO-VL, a multimodal agent that shifts the paradigm from monolithic generation to explainable, iterative, protocol-compliant structured report generation. Unlike deterministic models, our plan-act-observe loop functions as a goal-oriented agent: it first perceives the Chest X-Ray through an explainable vision module designed to capture inherent diagnostic uncertainty, then iteratively refines the generated report by observing semantic discrepancies and self-correcting its generation for better alignment with visually detected clinical findings. Evaluation of our framework demonstrates that this agentic reasoning improves clinical correctness and completeness, achieving an expert-rated accuracy score of 3.5/5 and a structural score of 4.3/5. By prioritizing pathology specific explainability and iterative refinement over opaque end-to-end mapping, MedPAO-VL offers a transparent and clinically viable alternative for automated structured radiology report generation.

0.22

PlanPath: Exploration-Guided Orchestration for Patient-Level Pathology Reasoning

cs.CV cs.MA ·2026-10-13 ·Jiusong Ge, Mingzhao He, Qidong Liu, Chunbao Wang, Chunze Yang +6 more
code/data similarity 0.63
Abstract

A patient's pathology case spans tens of slides from distinct specimens and anatomical sites, each carrying non-redundant, site-specific evidence. Forming a patient-level conclusion therefore requires locating the slides relevant to a given question and integrating complementary findings across them. However, existing pathology agents analyze one slide at a time and describe morphology rather than measure it, leaving evidence acquisition across a patient's specimens and patient-level quantification underexplored. To address this gap, we propose PlanPath, an agentic framework for patient-level pathology visual question answering (VQA). PlanPath turns the question into an exploration plan that specifies the evidence required, routes to the slides likely to carry it, and drives coarse-to-fine acquisition from tissue architecture down to individual cells. Tissue- and cell-level tools supply the counts, proportions, and extents, which PlanPath aggregates across slides into a traceable answer. To enable evaluation, we build two patient-level VQA datasets for renal and gastric cancer, averaging 15 WSIs per patient, with pathologist-verified question-answer pairs derived from diagnostic reports. Experimental results show that PlanPath outperforms the strongest baseline by 9.4% and 12.1% in overall accuracy on the two datasets and further improves existing slide-level agents when plugged into our framework. The dataset and code are available at: https://github.com/JSGe-AI/PlanPath_1.

0.39